Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dmitri D. Kharkevitch"'
Autor:
Agop Y. Bedikian, Eric D. Whitman, Dmitri D. Kharkevitch, Rene Gonzalez, Michael B. Atkins, Jon M. Richards
Publikováno v:
Melanoma Research. 20:218-226
Allovectin-7, a bicistronic plasmid encoding human leukocyte antigen-B7 and beta-2 microglobulin formulated with a cationic lipid system, is an immunotherapeutic agent designed to express allogeneic major histocompatibility complex class I antigen up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce98b2a24b443da12203c80b5004c07
https://doi.org/10.1097/cmr.0b013e3283390711
https://doi.org/10.1097/cmr.0b013e3283390711
Autor:
Dmitri D. Kharkevitch, Charles M. Balch, Glen C. Balch, Tomoyuki Maeda, Kyogo Itoh, Dai Seito
Publikováno v:
International Journal of Cancer. 58:317-323
Human autologous tumor-specific T-helper 2 (Th2) cells were investigated in melanoma tumor-infiltrating lymphocytes (TILs). Both a CD4+ T-cell line and its 5 potential T-cell clones established from TILs of a patient with metastatic melanoma produced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51a1ccf4eb906823e745824a0bb8f22
https://doi.org/10.1002/ijc.2910580302
https://doi.org/10.1002/ijc.2910580302
Autor:
Dmitri D. Kharkevitch, Richard T. Kenney, John Schulte, Larry R. Smith, Mary K. Wloch, Alice Chu, Alain Rolland
Publikováno v:
Journal of Clinical Oncology. 30:e19058-e19058
e19058 Background: Velimogene aliplasmid (Allovectin, A) is a plasmid-based immunotherapeutic that encodes human leukocyte antigen-B7 and β-2 microglobulin. A is designed to induce allogeneic and tumor-antigen-specific T-cell responses against tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de12ae04e503d56a41c615dc36ec8086
https://doi.org/10.1200/jco.2012.30.15_suppl.e19058
https://doi.org/10.1200/jco.2012.30.15_suppl.e19058
Autor:
Alice Chu, L. R. Muenz, Alain Rolland, Richard T. Kenney, Dmitri D. Kharkevitch, L. G. Strause
Publikováno v:
Journal of Clinical Oncology. 29:8572-8572
8572 Background: Allovectin is a plasmid-based immunotherapy expressing HLA-B7 and β2 microglobulin genes designed to stimulate both local and systemic anti-tumor responses. In a phase II single-ar...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b5033229d93bc0939ee834196aa8229
https://doi.org/10.1200/jco.2011.29.15_suppl.8572
https://doi.org/10.1200/jco.2011.29.15_suppl.8572
Autor:
Bedikian AY; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA., Richards J, Kharkevitch D, Atkins MB, Whitman E, Gonzalez R
Publikováno v:
Melanoma research [Melanoma Res] 2010 Jun; Vol. 20 (3), pp. 218-26.